This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2013 Sep 10;128(11):1256-67.

doi: 10.1161/CIRCULATIONAHA.113.000962.

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

Robert S Rosenson¹, H Bryan Brewer Jr, Benjamin Ansell, Philip Barter, M John Chapman, Jay W Heinecke, Anatol Kontush, Alan R Tall, Nancy R Webb

Affiliations

Affiliation

¹ Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.S.R.); Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC (H.B.B.); Atherosclerosis Research Unit, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA (B.A.); Centre for Vascular Research at the University of New South Wales, Sydney, Australia (P.B.); Dyslipidemia, Atherosclerosis and Inflammation Research Unit 939, National Institute for Health and Medical Research, University of Pierre and Marie Curie - Paris 6, Pitie-Salpetriere Hospital, Paris, France (M.J.C., A.K.) Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle (J.W.H.); Department of Medicine, Columbia University, New York, NY (A.R.T.); and Internal Medicine and Saha Cardiovascular Research Center, University of Kentucky College of Medicine, Lexington (N.R.W.).

PMID: 24019446
DOI: 10.1161/CIRCULATIONAHA.113.000962

Review

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

Robert S Rosenson et al. Circulation. 2013.

. 2013 Sep 10;128(11):1256-67.

doi: 10.1161/CIRCULATIONAHA.113.000962.

Authors

Robert S Rosenson¹, H Bryan Brewer Jr, Benjamin Ansell, Philip Barter, M John Chapman, Jay W Heinecke, Anatol Kontush, Alan R Tall, Nancy R Webb

Affiliation

¹ Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.S.R.); Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC (H.B.B.); Atherosclerosis Research Unit, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA (B.A.); Centre for Vascular Research at the University of New South Wales, Sydney, Australia (P.B.); Dyslipidemia, Atherosclerosis and Inflammation Research Unit 939, National Institute for Health and Medical Research, University of Pierre and Marie Curie - Paris 6, Pitie-Salpetriere Hospital, Paris, France (M.J.C., A.K.) Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle (J.W.H.); Department of Medicine, Columbia University, New York, NY (A.R.T.); and Internal Medicine and Saha Cardiovascular Research Center, University of Kentucky College of Medicine, Lexington (N.R.W.).

PMID: 24019446
DOI: 10.1161/CIRCULATIONAHA.113.000962

No abstract available

Keywords: atherosclerosis; cardiovascular diseases; inflammation; lipids; lipoproteins.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations